tradingkey.logo

BRIEF-Vertex Pharmaceuticals Announces Reimbursement Agreement With NHS England For CASGEVY

ReutersJan 31, 2025 7:33 AM

- Vertex Pharmaceuticals Inc VRTX.O:

  • VERTEX ANNOUNCES CASGEVY® REIMBURSEMENT AGREEMENT FOR THE TREATMENT OF SICKLE CELL DISEASE IN ENGLAND

  • VERTEX ANNOUNCES CASGEVY® REIMBURSEMENT AGREEMENT FOR THE TREATMENT OF SICKLE CELL DISEASE IN ENGLAND

  • VERTEX PHARMACEUTICALS INC - NICE ISSUES POSITIVE GUIDANCE FOR CASGEVY USE IN NHS

Source text: ID:nBwqXsBa

Further company coverage: VRTX.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI